Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort

BACKGROUND: We aimed to estimate the seroprevalence of SARS-CoV-2 infection in France and to identify the populations most exposed during the first epidemic wave. METHODS: Random selection of individuals aged 15 years or over, from the national tax register (96% coverage). Socio-economic data, migra...

Descripción completa

Detalles Bibliográficos
Autores principales: Warszawski, Josiane, Beaumont, Anne-Lise, Seng, Rémonie, de Lamballerie, Xavier, Rahib, Delphine, Lydié, Nathalie, Slama, Rémy, Durrleman, Sylvain, Raynaud, Philippe, Sillard, Patrick, Beck, François, Meyer, Laurence, Bajos, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743062/
https://www.ncbi.nlm.nih.gov/pubmed/35000580
http://dx.doi.org/10.1186/s12879-021-06973-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743062/
https://www.ncbi.nlm.nih.gov/pubmed/35000580
http://dx.doi.org/10.1186/s12879-021-06973-0

Ejemplares similares